To delineate the structural connectome alterations in patients with chronic migraine (CM), episodic migraine (EM), and healthy controls (HCs). The pathogenesis of migraine chronification remains elusive, with structural brain network changes potentially playing a key role. However, there is a paucity of research employing graph theory analysis to explore changes in the whole brain structural networks in patients with CM and EM. The individual structural brain connectome of 60 patients with CM, 34 patients with EM, and 39 healthy control participants were constructed by using deterministic diffusion-tensor tractography. Graph metrics including global efficiency, characteristic path length, local efficiency, clustering coefficient, and small-world parameters were evaluated to describe the topologic organization of the white matter structural networks. Additionally, nodal clustering coefficient and efficiency were considered to assess the regional characteristics of the brain connectome. A graph-based statistic was used to assess brain network properties across the groups. Graph theory analysis revealed significant disruptions in the structural brain networks of CM patients, characterized by reduced global efficiency, local efficiency, and increased characteristic path length compared to HCs. Additionally, CM patients exhibited significantly lower local efficiency than EM patients. Notably, the CM group demonstrated marked reductions in local clustering coefficient and nodal local efficiency in the frontal and temporal regions compared with the healthy control group and EM group. Nodal local efficiency can effectively distinguish CM from EM and HCs. Moreover, the disrupted topologic efficiency was significantly associated with attack frequency and MIDAS score in patients with migraine after Bonferroni correction. Decreased structural connectivity in the frontal and temporal regions may serve as a neuroimaging marker for migraine chronification and disease progression, providing valuable insights into the pathophysiology of chronic migraine.
12 March 2026 in Journal of Oral & Facial Pain and Headache
Background: Emerging evidence suggests that disturbances in lipid metabolism play a significant role in the etiology of migraines. However, the relationship between lipid metabolism disturbances and medication overuse headache (MOH) remains uncertain. This study aims to evaluate the association between elevated triglyceride (TG) levels and the occurrence of MOH among patients with chronic migraine (CM). Methods: A total of 267 hospitalized individuals diagnosed with CM were enrolled into the study. The participants were divided into two distinct groups based on the presence or absence of MOH. Questionnaires were employed for gathering demographic data, and a systematic inquiry was conducted to ascertain the overall prevalence of headaches. The laboratory examination, anxiety and depression scale, Pittsburgh sleep quality index, and other components were used to evaluate improvement. Initially, the study data underwent univariate analysis, whereby indicators demonstrating statistical significance (p < 0.05) were chosen as independent variables. Subsequently, a binary logistic regression analysis was conducted. Results: The cohort included a total of 87 patients without MOH and 180 patients with MOH. The following five risk variables emerged via single-factor analysis (p < 0.05): headache duration (years), headache frequency (days/months), headache intensity measured by a visual analogue scale (0–10), diabetes history, and TG levels. Elevated TG was associated with greater odds (OR = 1.498 (1.018, 2.259), p = 0.037) of MOH after accounting for demographics, headache features, and cardiometabolic comorbidities (including diabetes and hypertension). Conclusions: Elevated TG levels may be associated with MOH in patients with CM, underscoring their importance in the diagnostic evaluation and therapeutic management of patients with CM.
Objective: As a neurovascular disorder, migraine currently lacks well‐established macroscopic biomarkers detectable by magnetic resonance angiography (MRA). While the basilar artery (BA) has been implicated in migraine pathophysiology, this relationship remains poorly characterized. This study investigates whether BA morphological parameters could serve as diagnostic biomarkers for migraine and predictive markers for disease progression. Methods: This study included 41 healthy controls (HCs), 41 episodic migraine (EM) patients, and 95 chronic migraine (CM) patients who completed both MRI examinations and standardized questionnaires. Using established diagnostic criteria for vertebrobasilar dolichoectasia (VBD), we quantified the diameter, length, and height of the BA bifurcation. Furthermore, we measured the superior cerebellar artery (SUCA) outlet angle and basilar artery lateral displacement (BALD). These BA‐derived metrics were subsequently incorporated into multivariable logistic regression models to assess their predictive value for migraine chronification. Results: No significant differences were found in BA diameter, BA length, BADE, or VBD when comparing either EM or CM groups with HCs. However, both BALD and SUCA outlet angles showed significant intergroup differences. There was a statistically significant difference in BADE between EM and CM. In the logistic regression, migraine was significantly associated with both BALD and SUCA outlet angles. In the multinomial logistic regression analysis, EM was significantly associated with SUCA outlet angle, while CM was significantly associated with both BALD and SUCA outlet angle. Conclusions: Our data suggest that the reduced SUCA outlet angle may represent a risk factor for migraine and could potentially serve as an imaging biomarker. Additionally, BALD may constitute an independent risk factor for CM and could function as an MRA biomarker for migraine chronicity. Potential indicators related to the basilar artery may influence migraine attacks by affecting hemodynamic changes in migraine pathophysiology.